Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus

Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus

Abstract Background Diabetes mellitus (DM) is a chronic progressive metabolic disease that involves uncontrolled elevation of blood glucose levels. Among various therapeutic approaches, GLP-1 prevents type 2 diabetes mellitus (T2DM) patients from experiencing hyperglycemic episodes. However, the sho...

Full description

Bibliographic Details
Main Authors:	Seungbin Cha, Sun Hwa Lee, Sung Hun Kang, Mohammad Nazmul Hasan, Young Jun Kim, Sungpil Cho, Yong-Kyu Lee
Format:	Article
Language:	English
Published:	BMC 2018-07-01
Series:	Biomaterials Research
Subjects:	Type 2 diabetes GLP-1 Oral gene delivery FcRn
Online Access:	http://link.springer.com/article/10.1186/s40824-018-0129-7

Similar Items

Characterisation of the porcine neonatal Fc receptor
by: Stirling, Catriona M. A.
Published: (2002)

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
by: Tommy Li, et al.
Published: (2018-10-01)

Etapes précoces de l'infection du virus de l'hépatite C : endocytose et rôle potentiel du FcRn dans la modulation de sa neutralisation
by: Morel, Anthony
Published: (2016)

Oral uptake and persistence of the FnAb-8 protein characterized by in situ radio-labeling and PET/CT imaging
by: Qian Wang, et al.
Published: (2020-11-01)

Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
by: Geert van Tetering, et al.
Published: (2020-12-01)

Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor
by: Piche-Nicholas, Nicole Melissa
Published: (2016)

Advances in therapeutic Fc engineering - modulation of IgG associated effector functions and serum half-life
by: Abhishek Saxena, et al.
Published: (2016-12-01)

Tissues Expression, Polymorphisms Identification of FcRn Gene and Its Relationship with Serum Classical Swine Fever Virus Antibody Level in Pigs
by: Liu Yang, et al.
Published: (2012-08-01)

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference
by: Jinmin Lee, et al.
Published: (2018-11-01)

The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals
by: Björn Weström, et al.
Published: (2020-06-01)

An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
by: Chen Gilor, et al.
Published: (2021-09-01)

Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics
by: Kine Marita Knudsen Sand, et al.
Published: (2015-01-01)

The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups
by: Philip R Cooper, et al.
Published: (2014-10-01)

Regulation of immune responses by the neonatal Fc receptor and its therapeutic implications
by: Timo eRath, et al.
Published: (2015-01-01)

Expression du récepteur FcRn et pharmacocinétique des anticorps thérapeutiques
by: Passot, Christophe
Published: (2014)

Antibodies and their receptors: different potential roles in mucosal defence
by: Rachel eHorton, et al.
Published: (2013-07-01)

Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators
by: Marie Albrecht, et al.
Published: (2020-03-01)

Trafficking analyses of FcRn and IgG ligand in the post-Brambell era
by: E. Sally eWard, et al.
Published: (2015-07-01)

Opinion: There’s been a flaw in our thinking.
by: Clark Lawrence Anderson
Published: (2014-10-01)

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
by: Céline Monnet, et al.
Published: (2021-08-01)

Prediction of the pharmacokinetics, pharmacodynamics and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model.
by: Manoranjenni eChetty, et al.
Published: (2015-01-01)

Fully human monoclonal antibody inhibitors of the neonatal Fc receptor (FcRn) reduce circulating IgG in nonhuman primates
by: Andrew E Nixon, et al.
Published: (2015-04-01)

Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes
by: Noémie Corcos, et al.
Published: (2021-08-01)

Activation of FcRn Mediates a Primary Resistance Response to Sorafenib in Hepatocellular Carcinoma by Single-Cell RNA Sequencing
by: Xin Guan, et al.
Published: (2021-08-01)

Possible Mechanisms by Which Enzymatic Degradation of Human Serum Albumin Can Lead to Bioactive Peptides and Biomarkers
by: Ulrich Kragh-Hansen
Published: (2018-07-01)

Pemphigus: Current and Future Therapeutic Strategies
by: Dario Didona, et al.
Published: (2019-06-01)

A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen
by: Oskar Vilhelmsson Timmermand, et al.
Published: (2021-07-01)

IgG subclasses and allotypes: from structure to effector functions
by: Gestur eVidarsson, et al.
Published: (2014-10-01)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
by: Liming Liu
Published: (2017-04-01)

Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans
by: Alyssa Marie M. Castillo, et al.
Published: (2021-07-01)

The role of FcRn in antigen presentation
by: Kristi eBaker, et al.
Published: (2014-08-01)

Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
by: Joanna E. Mikulska
Published: (2018-07-01)

Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model
by: Miriam Manook, et al.
Published: (2021-06-01)

Effet thérapeutique du cetuximab administré par aérosol dans un modèle animal de tumeur broncho-pulmonaire : importance du récepteur Fc Rn dans la réponse anti-tumorale à cet anticorps.
by: Maillet, Agnès
Published: (2008)

Selection of IgG variants with increased FcRn binding using random and directed mutagenesis: impact on effector functions
by: Céline eMonnet, et al.
Published: (2015-02-01)

Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport
by: Simone Mader, et al.
Published: (2018-07-01)

Emerging Therapies in Immune Thrombocytopenia
by: Sylvain Audia, et al.
Published: (2021-03-01)

Facteurs immunologiques et génétiques impliqués dans la variabilité de la pharmacocinétique des anticorps thérapeutiques
by: Magdelaine, Charlotte
Published: (2010)

Human FcRn can mediate the transport across intestinal mucosal barrier and prolong the half-life of rabbit IgG in vivo
by: Guangchang Pang, et al.
Published: (2015-06-01)

Interactions of IgG1 CH2 and CH3 domains with FcRn
by: Tianlei eYing, et al.
Published: (2014-04-01)